Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2

被引:64
|
作者
Bruchas, Michael R. [1 ]
Xu, Mei [1 ]
Chavkin, Charles [1 ]
机构
[1] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
关键词
beta-arrestin-dependent signaling; dynorphin; the extracellular signal-regulated kinase 1/2; mitogen-activated protein kinase; forced swim G-protein coupled receptor kinase; stress-induced; immobility; kappa opioid receptor;
D O I
10.1097/WNR.0b013e32830dd655
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Earlier studies identified the dynorphin-kappa opioid receptor (KOR) system as a critical mediator of dysphoria-induced aversion after repeated stress exposure, but the molecular signaling mechanisms were not fully characterized. In this study we report that repeated forced swim stress caused a significant phosphorylation of extracellular signal-regulated kinase (ERK)1/2 a mitogen-activated protein kinase (MAPK) in both the caudate and nucleus accumbens regions of the mouse striatum. Activation was blocked by the KOR antagonist, norbinaltorphimine, and absent in KOR knockout mice. In contrast to p38-MAPK activation by stress-induced dynorphin release, KOR-mediated ERK1/2 phosphorylation was not dependent on G-protein coupled receptor kinase 3 expression. These results indicate stress-induced activation of the dynorphin-KOR systems activates ERK1/2 MAPK signaling, and this may contribute to the behavioral responses to repeated stress exposure. NeuroReport 19:1417-1422 (C) 2008 Wolters Kluwer Health \ Lippincott Williams & Wilkins.
引用
收藏
页码:1417 / 1422
页数:6
相关论文
共 50 条
  • [11] The activity of the extracellular signal-regulated kinase 2 is regulated by differential phosphorylation in the activation loop
    Zhou, B
    Zhang, ZY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 13889 - 13899
  • [12] Repeated Exposure to the κ-Opioid Receptor Agonist Salvinorin A Modulates Extracellular Signal-Regulated Kinase and Reward Sensitivity
    Potter, David N.
    Damez-Werno, Diane
    Carlezon, William A., Jr.
    Cohen, Bruce M.
    Chartoff, Elena H.
    BIOLOGICAL PSYCHIATRY, 2011, 70 (08) : 744 - 753
  • [13] Involvement of protein kinase C in the activation of extracellular signal-regulated kinase 1/2 by UVC irradiation
    Zhuang, SG
    Hirai, S
    Mizuno, K
    Suzuki, A
    Akimoto, K
    Izumi, Y
    Yamashita, A
    Ohno, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (02) : 273 - 278
  • [14] Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation
    Jiménez-Sainz, MC
    Fast, B
    Mayor, F
    Aragay, AM
    MOLECULAR PHARMACOLOGY, 2003, 64 (03) : 773 - 782
  • [15] The integrin α5β1 regulates αvβ3-mediated extracellular signal-regulated kinase activation
    Ly, DP
    Corbett, SA
    JOURNAL OF SURGICAL RESEARCH, 2005, 123 (02) : 200 - 205
  • [16] Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance
    Bobeck, Erin N.
    Ingram, Susan L.
    Hermes, Sam M.
    Aicher, Sue A.
    Morgan, Michael M.
    BEHAVIOURAL BRAIN RESEARCH, 2016, 298 : 17 - 24
  • [17] Caveolin-1 regulates sheer stress-dependent activation of extracellular signal-regulated kinase
    Park, H
    Go, YM
    Darji, R
    Choi, JW
    Lisanti, MP
    Maland, MC
    Jo, H
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (04): : H1285 - H1293
  • [18] The activation of extracellular signal-regulated kinase is responsible for podocyte injury
    Shufang Liu
    Jie Ding
    Qingfeng Fan
    Han Zhang
    Molecular Biology Reports, 2010, 37 : 2477 - 2484
  • [19] Activation of extracellular signal-regulated kinase in trabecular meshwork cells
    Shearer, T
    Crosson, CE
    EXPERIMENTAL EYE RESEARCH, 2001, 73 (01) : 25 - 35
  • [20] Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats
    Bokemeyer, D
    Guglielmi, KE
    McGinty, A
    Sorokin, A
    Lianos, EA
    Dunn, MJ
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03): : 582 - 588